Related Experiment Videos
New drugs for Parkinson's disease
1University of Arkansas for Medical Sciences, College of Nursing, Little Rock 72205.
Summary
New Parkinson's disease (PD) treatments, including deprenyl and Sinemet CR, offer improved quality of life for patients. These pharmacological advancements aim to manage symptoms until a cure for PD is found.
Area of Science:
- Neurology
- Pharmacology
Background:
- Parkinson's disease affects nearly half a million Americans, significantly impacting quality of life.
- Ongoing research into Parkinson's disease (PD) drives improvements in pharmacological treatments.
Purpose of the Study:
- To review recent advancements in Parkinson's disease pharmacological treatment.
- To highlight the potential benefits of newly available and upcoming medications for PD patients.
Main Methods:
- Review of current pharmacological options for Parkinson's disease.
- Discussion of the therapeutic role of deprenyl and Sinemet CR.
Main Results:
- Deprenyl has recently been introduced as a treatment option for Parkinson's disease.
- Sinemet CR is anticipated to become available soon, offering another therapeutic choice.
Conclusions:
- Emerging drugs like deprenyl and Sinemet CR are expected to enhance patient outcomes in Parkinson's disease.
- These medications aim to improve both the quality and duration of life for individuals with PD, pending a definitive cure.